Sebastian Köhler Selected Research

Sebastian Köhler Research Topics

Disease

13	Cognitive Dysfunction 11/2021 - 02/2010
9	Stroke (Strokes) 01/2022 - 08/2013
9	Dementia (Dementias) 01/2020 - 01/2015
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2015
5	Albuminuria 11/2021 - 01/2017
5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 05/2015
4	Hypertension (High Blood Pressure) 01/2020 - 02/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2017
2	Prediabetic State (Prediabetes) 01/2022 - 11/2021
2	Diabetes Mellitus 01/2021 - 01/2020
2	Cerebral Small Vessel Diseases 01/2020 - 01/2020
2	Undiagnosed Diseases 01/2019 - 01/2016
2	Intellectual Disability (Idiocy) 01/2018 - 10/2010
2	Atrophy 05/2016 - 02/2010
1	COVID-19 01/2022
1	Infections 01/2022
1	Glucose Intolerance 11/2021
1	Infarction (Infarctions) 01/2021
1	Ischemic Stroke 01/2021
1	Insulin Resistance 11/2020
1	Frontotemporal Dementia (Semantic Dementia) 03/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Hyperemia 01/2020
1	Inflammation (Inflammations) 01/2020
1	Asthma (Bronchial Asthma) 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Atrial Fibrillation 01/2019
1	Seizures (Absence Seizure) 01/2018
1	Neurobehavioral Manifestations 01/2018
1	Brain Injuries (Brain Injury) 01/2018
1	Chronic Renal Insufficiency 01/2018
1	Muscle Hypotonia (Hypotonia) 01/2018
1	Multiple Sclerosis 01/2018
1	Hyperphosphatasia with Mental Retardation 01/2018
1	Disease Progression 01/2017
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2017
1	Fatigue 10/2016
1	Coronary Disease (Coronary Heart Disease) 01/2015
1	Obesity 01/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2010

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2015
5	CholesterolIBA 01/2022 - 01/2015
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2017
5	Apolipoproteins E (ApoE)IBA 01/2020 - 05/2010
3	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2017
3	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 02/2014
2	ORALIT (ORS)IBA 01/2022 - 01/2021
2	Biological ProductsIBA 01/2021 - 10/2016
2	LipidsIBA 01/2020 - 08/2015
2	ApolipoproteinsIBA 01/2020 - 01/2019
2	Retinaldehyde (Retinal)IBA 01/2020 - 01/2020
2	Alkaline PhosphataseIBA 01/2018 - 10/2010
2	CreatinineIBA 01/2018 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 05/2015
2	Cystatin CIBA 01/2018 - 01/2017
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	3-Hydroxyanthranilic AcidIBA 11/2021
1	xanthurenic acidIBA 11/2021
1	Kynurenic Acid (Kynurenate)IBA 11/2021
1	KynurenineIBA 11/2021
1	3-hydroxykynurenineIBA 11/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020
1	SelectinsIBA 01/2020
1	DiureticsIBA 01/2020
1	E-SelectinIBA 01/2020
1	HDL CholesterolIBA 01/2020
1	von Willebrand FactorIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Pharmaceutical PreparationsIBA 06/2019
1	CarbohydratesIBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	A-factor (Streptomyces)IBA 01/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2018
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2018
1	EnzymesIBA 01/2018
1	AlbuminsIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2017
1	2-bromolysergic acid diethylamide (BOL)IBA 10/2016
1	Genetic Markers (Genetic Marker)IBA 05/2016
1	Uridine Diphosphate (UDP)IBA 01/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2010
1	GlucocorticoidsIBA 02/2010

Therapy/Procedure

2	Activities of Daily Living (ADL) 03/2020 - 01/2018
1	Therapeutics 01/2021
1	Cognitive Training 01/2020
1	Secondary Prevention 01/2018
1	Stroke Rehabilitation 09/2017
1	Ambulatory Care (Outpatient Care) 05/2016